⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for metastatic medullary thyroid cancer

Every month we try and update this database with for metastatic medullary thyroid cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid CancerNCT00654238
Metastatic Diff...
Metastatic Poor...
Metastatic Anap...
Metastatic Medu...
sorafenib
18 Years - University of Pennsylvania
GFRα4 CAR T Cells in MTC PatientsNCT04877613
Metastatic Medu...
single dose of ...
Fludarabine
Cyclophosphamid...
18 Years - University of Pennsylvania
Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid CancerNCT00654238
Metastatic Diff...
Metastatic Poor...
Metastatic Anap...
Metastatic Medu...
sorafenib
18 Years - University of Pennsylvania
Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid CancerNCT00654238
Metastatic Diff...
Metastatic Poor...
Metastatic Anap...
Metastatic Medu...
sorafenib
18 Years - University of Pennsylvania
GFRα4 CAR T Cells in MTC PatientsNCT04877613
Metastatic Medu...
single dose of ...
Fludarabine
Cyclophosphamid...
18 Years - University of Pennsylvania
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: